investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Leveraging GxE interaction to understand pancreatic cancer and altered metabolism

Peter Kraft

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Peter Kraft

Harvard University

Cambridge, United States

Related projects

S Perwez Hussain

Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer

Pancreas

Pathology

Eric W Schmidt

AP 4. Drug Screening and Pharmacology

Pancreas

Bryan Q Spring

Online monitoring and image-guided treatment of chemoresistant micrometastases

Pancreas

Pathology

Robert M Straubinger

Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium

Pancreas

Pathology

Darren Richard Carpizo

Exploration of a Mutant p53 Reactivating Compound

Pancreas

Ronald A Depinho

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

Pancreas

Pathology

Gregory J Hannon

Cold Spring Harbor Laboratory Cancer Research Center

Pancreas

Bulent Ozpolat

Targeting Kras in Pancreatic Cancer

Pancreas

Udo Rudloff

Preclinical Drug Development in Pancreatic Cancer

Pancreas

Pathology